全球乳铁蛋白市场规模（按功能、应用、区域范围和预测）

乳铁蛋白市场规模及预测

预计 2024 年乳铁蛋白市场规模将达到 20.6 亿美元，到 2032 年将达到 44.9 亿美元，2026 年至 2032 年的复合年增长率为 7.9%。

消费者对健康和饮食的意识不断增强，以及皮肤相关健康问题发病率的上升，被认为是推动需求成长的因素。乳铁蛋白被认为具有抗病毒、抗菌、抗寄生虫、催化和抗过敏的活性和特性，这可能会刺激该产品在医药和个人护理领域的需求。根据美国皮肤病学会的数据，痤疮是美国最常见的皮肤问题，每年影响 4,000 万至 5,000 万人。全球乳铁蛋白市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场驱动因素、限制因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

定义全球乳铁蛋白市场

乳铁蛋白是一种源自牛奶的膳食补充品。它从牛中提取，并被配製成各种商业食品，包括个人护理用品、婴儿奶粉、牙膏和膳食补充剂。这种多功能蛋白质会根据温度、物理和化学条件发生构象变化。为了避免变性，需要增强和优化粗乳铁蛋白萃取物和含乳铁蛋白食品的加工过程。

它对改善胃溃疡、肠溃疡、腹泻和丙型肝炎尤其有效。它也能作为抗氧化剂，预防细菌和病毒性疾病。它对人体有多种健康益处，包括防止组织损伤、预防癌症和激活免疫反应。食用乳铁蛋白安全，但过量摄取可能会产生副作用。它在商店和网上很容易买到，通常以粉末形式出售。乳铁蛋白具有抗病毒、抗菌、抗致癌和抗发炎特性。这种蛋白质的抗菌和抗真菌特性主要作为人体的防御机制。乳铁蛋白具有抗菌和抗真菌特性，适合人类新生儿。

全球乳铁蛋白市场概览

痤疮在美国、加拿大和德国等已开发国家日益普遍，而关于使用乳铁蛋白治疗痤疮的可靠推荐和研究结果可能会在整个预测期内为产品製造商带来成长机会。全球个人保健部门规模达数十亿美元，正从传统的实体店业务转向利基市场和网路零售商。所有年龄层的女性都更喜欢跨渠道购买，她们会先访问在线门户网站了解产品信息，然后再从线下零售商处购买。

品牌商的行销活动提升了消费者的认知度，加上消费者对副作用更小、功效更高的有机产品的偏好，预计将进一步推动该产品的需求。乳铁蛋白广泛用于降低皮肤免疫反应，并透过活化表皮细胞结缔组织和重建皮肤来促进创伤治疗。其抗炎特性有助于防止更大的粉刺和囊肿的形成。多项临床研究表明，乳铁蛋白有助于治疗和预防胃肠道发炎疾病。

消费者对肠道健康的认知不断提升，以及对预防肠躁症和腹胀以及减轻肠道发炎产品的需求不断增长，预计将在整个预测期内推动乳铁蛋白市场的扩张。然而，与乳铁蛋白使用相关的不良反应（例如腹泻）预计将对乳铁蛋白市场的扩张构成重大障碍。乳铁蛋白的高价格预计将进一步阻碍市场扩张。政府推广母乳哺育的措施也预计将减缓乳铁蛋白市场的成长率。

目录

第一章全球乳铁蛋白市场介绍

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球乳铁蛋白市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球乳铁蛋白市场（依功能）

• 概述
• 铁的吸收
• 消炎（药）
• 保护肠内菌丛
• 抗菌
• 免疫细胞刺激
• 抗氧化作用

第六章 全球乳铁蛋白市场应用

• 概述
• 饮食
• 婴儿奶粉
• 运动机能性食品
• 製药
• 个人保健产品
• 餵食

第七章全球乳铁蛋白市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第八章全球乳铁蛋白市场竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第九章 公司简介

• InVitria
• Hilmar Cheese Company
• Glanbia plc
• Pharming Group NV
• APS BioGroup
• FrieslandCamina
• Synlait Milk Ltd.
• Ferrin-tech LLC
• Ingredia SA
• Tatura Milk Industries Ltd.

第十章 附录

• 相关调查

Lactoferrin Market Size And Forecast

Lactoferrin Market size was valued at USD 2.06 Billion in 2024 and is projected to reach USD 4.49 Billion by 2032, growing at a CAGR of 7.9% from 2026 to 2032.

The increased consumer awareness of health and diet, as well as the rising occurrence of skin-related health issues, are likely to drive demand. Lactoferrin is thought to offer antiviral, antibacterial, antiparasitic, catalytic, and anti-allergic activities and qualities, which will increase product demand in the pharmaceutical and personal care sectors. Acne is the most common skin problem in the United States, impacting 40 to 50 million individuals each year, according to the American Academy of Dermatology. The Global Lactoferrin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Lactoferrin Market Definition

Lactoferrin is a nutritional supplement derived from milk. Lactoferrin is extracted from bovine milk and then mixed into a variety of commercial food products, including personal care items, infant formula, toothpaste, and nutraceuticals. Temperature, as well as physical and chemical restrictions, can trigger conformational changes in this multi-function protein. To avoid denaturation, the lactoferrin crude extract and process factors for lactoferrin-containing food items should be enhanced and optimized.

Among other things, it can assist with stomach and intestinal ulcers, diarrhea, and hepatitis C. It also acts as an antioxidant, which protects against bacterial and viral illnesses. It provides several health advantages for the body, including tissue damage prevention, cancer prevention, immune response activation, and other benefits. It is safe to consume, but excessive doses might have negative consequences. It is readily accessible in stores and online. It is most often found as a powder. Lactoferrin has antiviral, antibacterial, anti-carcinogenic, and anti-inflammatory properties. The protein's antibacterial and antifungal activities serve largely as a defense mechanism in the body. Lactoferrin is antibacterial and antifungal, making it suitable for human newborns.

Global Lactoferrin Market Overview

Acne is becoming more common in developed countries such as the United States, Canada, and Germany, and confirmed testimonies and study findings for lactoferrin-induced acne therapy are likely to drive growth opportunities for product producers throughout the projection period. The worldwide personal care sector is worth billions of dollars and is shifting away from traditional brick-and-mortar businesses and towards niche and internet retailers. Women of all ages prefer a cross-channel purchase method, where they visit online portals to learn about the goods before purchasing from an offline retail location.

Consumer awareness as a result of brand owners' product marketing operations, along with a preference for organic products with fewer side effects and improved efficiency, is predicted to boost product demand even further. Lactoferrin is widely used in the reduction of dermal immune response and wound healing by activating connective tissue with epidermal cells and rebuilding the skin. Its anti-inflammatory properties help to prevent the production of bigger zits and cysts. Lactoferrin has been shown in several clinical trials to be useful in the treatment and prevention of gastrointestinal inflammatory diseases.

Rising consumer knowledge about gut health, along with rising product demand to avoid irritable bowel movement and bloating, as well as to reduce intestinal inflammation, is expected to drive the expansion of the Lactoferrin Market throughout the projected period. However, negative effects associated with lactoferrin use, such as diarrhea, will pose a significant hurdle to the expansion of the Lactoferrin Market. The high prices connected with lactoferrin will further stymie market expansion. Increased government attempts to promote breastfeeding will also slow the growth rate of the Lactoferrin Market.

Global Lactoferrin Market: Segmentation Analysis

The Global Lactoferrin Market is Segmented Based on Function, Application, And Geography.

Lactoferrin Market, By Function

• Iron Absorption
• Anti-Inflammatory
• Intestinal Flora Protection
• Antibacterial
• Immune Cell Stimulation
• Antioxidant

Based on Function, the market is segmented into Iron Absorption, Anti-Inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, and Antioxidant. The iron absorption segment generated the most revenue in 2022 and is predicted to continue its lead throughout the projection period. Iron deficiency frequently results in anemia, which affects around 30% of the world's population. Lactoferrin has been a critical remedy for anemia because of its high bioavailability and capacity to enhance serum ferritin levels by five times when compared to other iron sources. According to the WHO, anemia affects about 1.62 billion people worldwide, with pre-school-aged children having the highest incidence, accounting for 47.4% of the total afflicted population.

Lactoferrin Market, By Application

• Food & Beverages
• Infant Formula
• Sports & Functional Foods
• Pharmaceuticals
• Personal Care Products
• Animal Feed

Based on Application, the market is segmented into Food & Beverages, Infant Formula, Sports & Functional Foods, Pharmaceuticals, Personal Care Products, and Animal Feed. In 2022, the baby formula category led the Lactoferrin Market, accounting for the biggest revenue share. From 2023 to 2030, the category is predicted to grow at a stable CAGR. The increased number of clinical studies supporting baby formula integration with lactoferrin, as well as changing consumer dynamics towards newborn supplemental meals, are expected to drive demand. The demand for newborn nourishment is primarily from developed economies, owing to high disposable money, hectic work schedules, and increased rates of iron deficiency in newborns.

Lactoferrin Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Based on Regional Analysis, the Lactoferrin Market is classified into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2022, Asia Pacific will be the largest regional market. Throughout the projection period, the regional market is likely to maintain its position. The regional market expansion, led by India, China, and Japan, may be attributable to increased population and consumer purchasing capacity. Unlike most other areas, Asia Pacific contains a substantial number of middle and small firms.

• Furthermore, increased consumer knowledge about newborn nutrition, personal care, and pharmaceutical goods, as well as consumer preference for organic products, are likely to boost the market for lactoferrin in the area. In 2022, North America was the second-largest geographic market for lactoferrin. The United States has emerged as the region's largest market. The rising prevalence of digestive problems has increased product demand across the country.

Key Players

The "Global Lactoferrin Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as InVitria, Hilmar Cheese Company, Glanbia plc, Pharming Group NV, APS BioGroup, FrieslandCamina, Synlait Milk Ltd., Ferrin-tech LLC, Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, Milei GmbH.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In April 2022, Before it can be licensed for sale on the market, leniolisib, a possible therapy for activated phosphoinositide 3-kinase delta syndrome (APDS) in children, must first go through the regulatory procedure of having an agreed-upon Paediatric Investigation Plan (PIP). Leniolisib has been designated as a Promising Innovative Medicine (PIM), indicating that it may be eligible for the MHRA's Early Access to Medicines Scheme.
• In May 2021, Laura Kelly, Governor of Kansas, and Hilmar Cheese Company, Inc. officials announced that the company has opted to build a brand new, cutting-edge cheese and whey protein production plant in Dodge City, Kansas.
• In September 2020, FrieslandCampina WAMCO completed the acquisition of Nuticima's dairy business. This acquisition has improved Friesl and Campina's production capacity, allowing them to meet the rising demand in Nigeria for powder milk and evaporated milk.
• In October 2020, Milei GmbH reported an increase in lactoferrin manufacturing capacity to 170 tonnes, more than doubling the capacity in 2019. The net investment will be USD 18.3 million.
• In September 2020, FrieslandCampina Ingredients said that it would boost its lactoferrin production capacity in Veghel, Netherlands, by 60 metric tonnes by 2022. This will aid the company's strategic growth in the Early Life Nutrition and Adult Nutrition areas. FrieslandCampina Ingredients will be the world's largest manufacturer of lactoferrin, with a new capacity of 70 mt per year.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Lactoferrin Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Lactoferrin Market gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL LACTOFERRIN MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL LACTOFERRIN MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL LACTOFERRIN MARKET, BY FUNCTION

• 5.1 Overview
• 5.2 Iron Absorption
• 5.3 Anti-Inflammatory
• 5.4 Intestinal Flora Protection
• 5.5 Antibacterial
• 5.6 Immune Cell Stimulation
• 5.7 Antioxidant

6 GLOBAL LACTOFERRIN MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Food & Beverages
• 6.3 Infant Formula
• 6.4 Sports & Functional Foods
• 6.5 Pharmaceuticals
• 6.6 Personal Care Products
• 6.7 Animal Feed

7 GLOBAL LACTOFERRIN MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL LACTOFERRIN MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 InVitria
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Hilmar Cheese Company
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Glanbia plc
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Pharming Group NV
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 APS BioGroup
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 FrieslandCamina
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Synlait Milk Ltd.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Ferrin-tech LLC
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Ingredia SA
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Tatura Milk Industries Ltd.
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research